Gene Expression Profiles of Sporadic Canine Hemangiosarcoma Are Uniquely Associated with Breed
Beth A. Tamburini, Susan Trapp, Tzu Lip Phang et al. · 2009
Read Gene Expression Profiles of Sporadic Canine Hemangiosarcoma Are Uniquely Associated with Breed by Beth A. Tamburini, Susan Trapp, Tzu Lip Phang et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0005549.txt.
Introduction
Beth Tamburini and co-authors studied a blood vessel cancer in dogs for a 2009 PLOS ONE report. Hemangiosarcoma is a fast-moving cancer of blood vessel cells in dogs. Earlier work found set chromosome changes in tumours from golden retrievers that were rarer in other breeds.
The team compared gene activity in tumours across breeds. The patterns of activity tied closely to breed, even for tumours that arise without a known inherited cause. Breed background shaping tumour behaviour matters for dog care and may hint at similar effects in people. Dog cancers arise naturally and share features with human cancers, so breed lessons may run both ways.
Catalog record
| CREATOR | Beth A. Tamburini, Susan Trapp, Tzu Lip Phang et al. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 64 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0005549
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Gene Expression Profiles of Sporadic Canine Hemangiosarcoma Are Uniquely Associated with Breed Authors: Beth A. Tamburini, Susan Trapp, Tzu Lip Phang, Jill T. Schappa, Lawrence E. Hunter, Jaime F. Modiano Published: 2009, PLOS ONE DOI: 10.1371/journal.pone.0005549 ABSTRACT The role an individual's genetic background plays on phenotype and biological behavior of sporadic tumors remains incompletely understood. We showed previously that lymphomas from Golden Retrievers harbor defined, recurrent chromosomal aberrations that occur less frequently in lymphomas from other dog breeds, suggesting spontaneous canine tumors provide suitable models to define how heritable traits influence cancer genotypes. Here, we report a complementary approach using gene expression profiling in a naturally occurring endothelial sarcoma of dogs (hemangiosarcoma). Naturally occurring hemangiosarcomas of Golden Retrievers clustered separately from those of non-Golden Retrievers, with contributions from transcription factors, survival factors, and from pro-inflammatory and angiogenic genes, and which were exclusively present in hemangiosarcoma and not in other tumors or normal cells ( i.e. , they were not due simply to variation in these genes among breeds). Vascular Endothelial Growth Factor Receptor 1 (VEGFR1) was among genes preferentially enriched within known pathways derived from gene set enrichment analysis when characterizing tumors from Golden Retrievers versus other breeds. Heightened VEGFR1 expression in these tumors also was apparent at the protein level and targeted inhibition of VEGFR1 increased proliferation of hemangiosarcoma cells derived from tumors of Golden Retrievers, but not from other breeds. Our results suggest heritable factors mold gene expression phenotypes, and consequently biological behavior in sporadic, naturally occurring tumors. INTRODUCTION The role individual genetic backgrounds play on phenotypes and biological behavior of sporadic tumors remains to be determined in any species. Recent studies explored how race and ethnicity might influence gene expression and in turn contribute to disease susceptibility in humans, but few differences have been found [1] , [2] , [3] . Dog breeds may provide a useful surrogate for human ethnic groups. While dogs retain individual (outbred) traits, the derivation and maintenance of unique breeds has led to restricted gene pools. These restricted gene pools can be used to study heritable contributions to cancer susceptibility in animals that develop tumors spontaneously and share the human environment, but with the benefit of less “noise” from other phenotypic variation. Recent work has emphasized the utility of spontaneous canine tumors as a robust, non-redundant model that complements studies in humans and laboratory animals to understand cancer genetics [4] , [5] . For example, the degree of medical surveillance in dogs is second only to that in humans [6] ; diseases such as cancer, where traits are genetically complex and whose prevalence increases with inbreeding, are well documented in dogs [5] , [6] ; and dog populations are structured into >400 partially inbred isolates (breeds) and a heterogeneous population of mixed-breed dogs. Gene flow between breeds is restricted by pedigree barriers and dogs of different breeds are often more (or less) susceptible to different diseases [5] . Equally important, the canine genome closely resembles the human genome, pet dogs share the human environment, and the lifetime cancer risk in dogs and humans is similar [7] , [8] . Indeed, some cancers appear to occur more frequently in dogs and the incidence of many cancers varies according to breed, providing opportunities to study tumors that are difficult to replicate in humans or in inducible rodent models. Although cancer rates and incidence in dogs have not been established systematically in prospective or longitudinal studies, reproducible findings from retrospective analyses and breed health surveys provide reasonable estimates. Sporadic, naturally occurring hemangiosarcoma is relatively common in dogs (much more so than angiosarcoma in people, [9] with an apparent predilection for certain breeds such as German Shepherd Dogs, Boxers, and Golden Retrievers [9] , [10] , [11] , [12] , [13] , [14] . The association between breed and disease is strengthened by information from recent breed health surveys. For example, cancer is the apparent cause of death for more than 60% of Golden Retrievers in the U.S. and the lifetime risks for any cancer, for hemangiosarcoma, and for non-Hodgkin lymphoma in this breed are 1 in 2, 1 in 5, and 1 in 8, respectively [15] . In contrast, the lifetime risk for any cancer and for hemangiosarcoma in Irish Setters are estimated at 1 in 3 and 1 in 34, respectively [16] . Other breed health surveys suggest hemangiosarcoma also is common in Portuguese Water Dogs and Australian Shepherds, whereas it is diagnosed less frequently in English Cocker Spaniels, Rottweilers, Gordon Setters, and Vizslas, among others. Given the strong association between breed and risk, we predicted that gene expression profiles in tumors such as hemangiosarcoma also would reflect features uniquely associated with the breed. Furthermore, we anticipated that breed-related gene expression profiles would uncover biologically and therapeutically significant pathways that would inform etiology and identify therapeutic targets. Specifically, the central hypothesis was that naturally occurring hemangiosarcomas of Golden Retrievers would be distinguishable from histologically similar hemangiosarcomas of dogs from other breeds (non-Golden Retrievers) based on the overexpression or underexpression of genes preferentially concentrated in one or a few metabolic pathways, thus providing insights into the pathogenesis of this disease. To test this hypothesis, we used gene expression arrays and gene set enrichment analysis (GSEA) to identify genes that vary according to breed, as a proxy for heritability, in naturally occurring canine hemangiosarcoma. We hypothesized this would outline the potential influence of genetic background on cancer susceptibility and progression in a more unique way than simply comparing cancer cells to normal cells. For the first time, our data uncover unique gene sets that are peculiar to hemangiosarcoma tumors from a single dog breed (sharing a common genetic background). Overall, this study emphasizes the potential benefits of gene expression analysis and bioinformatics to study different biological aspects unique to a cancer susceptible dog breed and can fill gaps in our knowledge of disease susceptibility, heritability and progression. RESULTS While many human cancer cells have been shown to harbor different gene expression signatures compared to their normal counterpart cells ( e.g. , [17] ), little has been done to define gene expression profiles in canine tumors [18] . What is more, nothing has been done to outline how these phenotypes are influenced by heritable factors in any species. We showed elsewhere that hemangiosarcoma cells separate from non-malignant splenic hematoma cells based on gene expression profiles (Tamburini et al, manuscript in preparation). In this analysis, unsupervised clustering separated two major groups of hemangiosarcoma samples, consisting of tumors from Golden Retrievers and tumors from non-Golden Retrievers (GSE15086). Before we addressed potential differences in these two groups, however, we sought to ensure there were no hidden biases in the sample population. During the course of our study, we received blood samples from 76 dogs with pathologically confirmed hemangiosarcoma, including 48 Golden Retrievers and 28 non-Golden Retrievers. There were no differences between dogs in these two groups when comparing age at diagnosis (mean±S.D. = 9.3±2.6 and 8.6±2.6 years, respectively), gender (male vs. female, intact or neutered), location of the primary tumor, number of dogs treated, or outcome. The characteristics of the population were similar to those previously described both for Golden Retrievers [15] and for all dogs independent of breed [14]